Stay updated on Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record history now shows a new 42nd version, submitted November 3, 2026 and posted November 4, with a change to Study Status; the previously displayed June 18 date is no longer shown.SummaryDifference0.2%

- Check18 days agoChange DetectedThe ClinicalTrials.gov site revision shown in the footer changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check25 days agoChange DetectedA banner announces an NIH website terminology transition, stating that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) under Executive Order 14434.SummaryDifference0.4%

- Check32 days agoChange DetectedThe website footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check39 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry, v3.7.0, was added to the study history. The previous revision v3.6.6 was removed.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.